IN THE PHASE 3 BOREAS TRIAL, DUPILUMAB REDUCED FENO LEVELS OVER TIME IN PATIENTS WITH MODERATE OR SEVERE SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH TYPE 2 INFLAMMATION

Details

Language :

English

ISSN :

00123692 and 19313543

Volume :

166

Issue :

4, Number 4 Supplement 1

Database :

Supplemental Index

Journal :

Chest

Publication Type :

Periodical

Accession number :

ejs67414936

Full Text :

https://doi.org/10.1016/j.chest.2024.06.2871